Skip to main content

Understanding the Causes of Cancer

What Causes Cancer?

Most, if not all cancers are caused and perpetuated by a small population of tumor-initiating cells that exhibit numerous stem cell-like properties. Adult stem cells (SC) are involved in the regeneration and maintenance of our body tissues and account for one out of every 6 million cells. Each tissue has a unique population of specific SCs located in regions known as niches. In the SC niche, the SCs exist in a unique dormant state known as quiescence, and remain in this state until they are given the cues to be activated.

Activated stem cells go through two stages of development referred to as proliferation and differentiation. During proliferation, biochemical cues cause the cells to reproduce, resulting in an expanded population of similar cells. Differentiation puts a stop to proliferation with specific biochemical cues that cause the proliferating cells to differentiate into a specific type of cell. Once a stem cell has differentiated, it has a finite life span and is limited in how many times it can reproduce. The number of times a differentiated cell can reproduce is referred to as its Hayflick number.

Cancer results when a stem cell is stuck in proliferation, and is therefore not given the cues to differentiate. This situation results in a continually expanding population of undifferentiated cells that can not only exist anywhere in the body (metastasis), but also have unlimited life spans (no Hayflick number).

The biochemical cues for proliferation and differentiation are based on genes specific to each tissue type. In general, genes that initiate proliferation are called oncogenes while genes that initiate differentiation are called tumor suppressors. Cancer, therefore, could be seen as an over-activation of oncogenes accompanied by the inhibition of tumor suppressors. It is the ratio of oncogenes to tumor suppressors that determines the aggressiveness of the cancer.

Another key piece in the growth of cancers is a process called angiogenesis. Angiogenesis is the physiological process that tumors use in order to recruit new blood vessels in order to sustain their continual growth. They do this by over-expressing genes that initiate and direct the growth of new, leaky blood vessels from existing ones. Both angiogenesis and the spontaneous formation of new blood vessels (vasculogenesis) are initiated by unique combinations of genes.

Standard chemotherapeutic agents inhibit rapidly dividing cells during treatment, but do not affect dormant cancer initiating SCs. An example of this is shown in a side affect of treatment. During chemotherapy, patients lose their hair (rapidly dividing cells), but their hair typically grows back soon after treatment. This is due to the dormant SCs located in the hair shaft, which were not affected by the chemotherapy. It is this presence of dormant cancer initiating SCs combined with the occurrence of angiogenesis in-between treatment regimes that leads to disease recurrence.

The following link allows you to access the genes involved with various types of cancers.

http://www.genome.jp/kegg/

Alex Rolland is a cancer researcher, educator, and CEO of Cancer treatment Options and Management (http://www.ctoam.com/). CTOAM is a personalized cancer research company that specializes in using the most current peer reviewed scientific research on cancer diagnostics, treatments, nutraceuticals, and clinical trials to educate patients on the treatments and diets that provide the best statistical chances for success.


View the original article here

Labels:

Popular posts from this blog

Who should get a CT scan to screen for lung cancer?

By Jenifer Goodwin HealthDay Reporter THURSDAY, June 30 (HealthDay News) -- Annual low-dose CT scans cut the death rate from lung cancer by 20% in heavy smokers and formerly heavy smokers, compared to those who get annual chest X-rays, according to the results of a major National Cancer Institute study released on Wednesday. Experts are calling the findings a major advance in efforts to combat lung cancer deaths. By catching the cancer early, the tumors can be removed surgically -- hopefully before they've spread and become very difficult to cure. "This is a momentous time in the history of public health research," said Dr. Otis Brawley, chief medical officer of the American Cancer Society. "The NLST [National Lung Screening Trial] is the best-designed and best-performed lung cancer screening study in history." Yet the findings raise as many questions as they answer, said Dr. Harold Sox, a professor emeritus of medicine at Dartmouth Medical School who wrote an...
Read more

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...
Read more

What is Lung Cancer - Incidence, Signs, Symptoms, Causation, Prognosis and Treatment

INTRODUCTION Lung cancer may also be the most tragic cancer because in most cases, it might have been prevented, 87% of lung cancer cases are caused by smoking. Lung cancer has long been the most common cause of cancer death in men and since 1987 it has also become the most common cause of cancer death in women. Lung cancer is the second most commonly occurring form of cancer in most western countries and although the lung cancer incidence is less common in developing countries, the rapid increase in the popularity of smoking will see the number of lung cancer sufferers in those countries quickly catch up with the western world. Lung cancers can arise in any part of the lung, and 90%-95% of cancers of the lung are thought to arise from the epithelial, or lining cells of the larger and smaller airways (bronchi and bronchioles); for this reason, lung cancers are sometimes called bronchogenic carcinomas or bronchogenic cancers. The most common type of lung cancers are epidermoid carcinoma...
Read more